Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1725 | 6072 | 34.8 | 64% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
385 | 29018 | ANTIPHOSPHOLIPID SYNDROME//SYSTEMIC LUPUS ERYTHEMATOSUS//ANTIPHOSPHOLIPID ANTIBODIES |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
5310 | 1574 | INFANT DOSE//DEGRA//PREGNANCY POSTPARTUM MOOD DISORDERS PROGRAM |
6789 | 1367 | PREGNANCY AFTER TRANSPLANTATION//TRANSPLANTAT PREGNANCY REGISTRY//ISCARE |
11957 | 878 | HYPEREMESIS GRAVIDARUM//NAUSEA AND VOMITING OF PREGNANCY//NAUSEA AND VOMITING IN PREGNANCY |
12791 | 818 | MOTHERS RHEUMAT DIS//PREGNANCY RHEUMAT DIS//LUPUS PREGNANCY |
14372 | 707 | SUICIDE ATTEMPT DURING PREGNANCY//PREGNANCY AGE//HUMAN GENET TERATOL |
15370 | 646 | MATERNAL ASTHMA//PREGNANCY RHINITIS//ASTHMA MEDICATIONS |
33925 | 82 | CHRONIC LIVER INSUFFICIENCY//HPPOLE MED//CHIRROSIS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HYPEREMESIS GRAVIDARUM | Author keyword | 214 | 67% | 3% | 195 |
2 | MOTHERISK PROGRAM | Address | 69 | 40% | 2% | 133 |
3 | NAUSEA AND VOMITING OF PREGNANCY | Author keyword | 67 | 89% | 1% | 31 |
4 | NAUSEA AND VOMITING IN PREGNANCY | Author keyword | 29 | 88% | 0% | 14 |
5 | SUICIDE ATTEMPT DURING PREGNANCY | Author keyword | 27 | 92% | 0% | 11 |
6 | NAUSEA AND VOMITING OF PREGNANCY NVP | Author keyword | 23 | 100% | 0% | 10 |
7 | MORNING SICKNESS | Author keyword | 18 | 65% | 0% | 17 |
8 | HUMAN GENET TERATOL | Address | 17 | 40% | 1% | 33 |
9 | PREGNANCY AGE | Author keyword | 15 | 88% | 0% | 7 |
10 | PREGNANCY RHEUMAT DIS | Address | 14 | 100% | 0% | 7 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MATERNAL USE | 184 | 77% | 2% | 127 |
2 | MATERNAL ASTHMA | 76 | 64% | 1% | 74 |
3 | FEMALE KIDNEY | 69 | 96% | 0% | 22 |
4 | PSYCHOTROPIC MEDICATION EXPOSURE | 65 | 95% | 0% | 21 |
5 | 1ST TRIMESTER EXPOSURE | 56 | 72% | 1% | 44 |
6 | N DESMETHYLDOXEPIN | 52 | 100% | 0% | 18 |
7 | NURSING INFANTS SERUM | 52 | 100% | 0% | 18 |
8 | HYPEREMESIS GRAVIDARUM | 46 | 34% | 2% | 111 |
9 | NURSING INFANTS | 44 | 67% | 1% | 39 |
10 | 1ST TRIMESTER USE | 42 | 94% | 0% | 15 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Electroconvulsive therapy during pregnancy: a systematic review of case studies | 2015 | 2 | 46 | 70% |
Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence | 2015 | 2 | 103 | 57% |
State of the art: Reproduction and pregnancy in rheumatic diseases | 2015 | 3 | 106 | 36% |
Selected Pregnancy and Delivery Outcomes After Exposure to Antidepressant Medication A Systematic Review and Meta-analysis | 2013 | 42 | 77 | 58% |
A meta-analysis of adverse perinatal outcomes in women with asthma | 2011 | 55 | 61 | 92% |
A Systematic Review and Meta-Analysis of Pregnancy Outcomes in Patients with Systemic Lupus Erythematosus and Lupus Nephritis | 2010 | 76 | 46 | 74% |
Recent Changes in Pregnancy and Lactation Labeling: Retirement of Risk Categories | 2014 | 11 | 10 | 60% |
Antidepressant use in pregnancy: a critical review focused on risks and controversies | 2013 | 30 | 131 | 71% |
The transfer of drugs and other chemicals into human milk | 2001 | 401 | 198 | 48% |
Management of Critical Asthma Syndrome During Pregnancy | 2015 | 2 | 42 | 45% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOTHERISK PROGRAM | 69 | 40% | 2.2% | 133 |
2 | HUMAN GENET TERATOL | 17 | 40% | 0.5% | 33 |
3 | PREGNANCY RHEUMAT DIS | 14 | 100% | 0.1% | 7 |
4 | MOTHERS RHEUMAT DIS | 13 | 80% | 0.1% | 8 |
5 | DEGRA | 11 | 100% | 0.1% | 6 |
6 | PREGNANCY POSTPARTUM MOOD DISORDERS PROGRAM | 11 | 100% | 0.1% | 6 |
7 | TERATOL INFORMAT SERV | 9 | 43% | 0.3% | 16 |
8 | ISRAELI TERATOGEN INFORMAT SERV | 9 | 59% | 0.2% | 10 |
9 | FDN COMMUNITY CONTROL HEREDITARY DIS | 8 | 56% | 0.2% | 10 |
10 | MOTHERSAFE | 8 | 100% | 0.1% | 5 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000020975 | POSTPARTUM DEPRESSION//POSTNATAL DEPRESSION//EDINBURGH POSTNATAL DEPRESSION SCALE |
2 | 0.0000014254 | FOX FORDYCE DISEASE//DECIDUOSIS//ECTOPIC DECIDUA |
3 | 0.0000009417 | PRE ECLAMPSIA//HYPERTENSION IN PREGNANCY//HELLP SYNDROME |
4 | 0.0000008890 | ANTIPHOSPHOLIPID SYNDROME//ANTIPHOSPHOLIPID ANTIBODIES//LUPUS ANTICOAGULANT |
5 | 0.0000008310 | EMBRYONIC STEM CELL TEST//2 BUTOXYETHANOL//GLYCOL ETHERS |
6 | 0.0000006772 | 17 BETA AMINOESTROGENS//PROLAME//PENTOLAME |
7 | 0.0000006384 | CONGENITAL HEART BLOCK//NEONATAL LUPUS//NEONATAL LUPUS ERYTHEMATOSUS |
8 | 0.0000005878 | THIOPURINE METHYLTRANSFERASE//6 MERCAPTOPURINE//THIOPURINE S METHYLTRANSFERASE |
9 | 0.0000005805 | GASTROSCHISIS//OMPHALOCELE//ABDOMINAL WALL DEFECTS |
10 | 0.0000005719 | SYSTEMIC LUPUS ERYTHEMATOSUS//LUPUS//LUPUS NEPHRITIS |